Search Results - "Hatzimichael, Eleftheria C."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Serum interleukin (IL)‐1, IL‐2, sIL‐2Ra, IL‐6 and thrombopoietin levels in patients with chronic myeloproliferative diseases by Panteli, Katerina E., Hatzimichael, Eleftheria C., Bouranta, Paraskevi K., Katsaraki, Afroditi, Seferiadis, Konstantinos, Stebbing, Justin, Bourantas, Konstantinos L.

    Published in British journal of haematology (01-09-2005)
    “…Summary A number of growth factors are involved in clonal haematopoietic expansion and their clinical significance in patients with chronic myeloproliferative…”
    Get full text
    Journal Article
  2. 2

    Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients by Sfagos, Constantinos, Makis, Alexandros C, Chaidos, Aristeidis, Hatzimichael, Eleftheria C, Dalamaga, Androniki, Kosma, Katerina, Bourantas, Konstantinos L.

    Published in Multiple sclerosis (01-06-2005)
    “…Over the last few years, increased evidence has supported the role of iron dysregulation in the pathogenesis of multiple sclerosis (MS), as iron is essential…”
    Get full text
    Journal Article
  3. 3

    Serum levels of soluble interleukin-2 receptor alpha (sIL-2Rα) as a predictor of outcome in brucellosis by Makis, Alexandros C., Galanakis, Emmanouil, Hatzimichael, Eleftheria C., Papadopoulou, Zoe L., Siamopoulou, Antigone, Bourantas, Konstantinos L.

    Published in The Journal of infection (01-10-2005)
    “…Brucellosis is characterized by chronicity and relapses despite efficacious treatment. Cytokines and especially the Th1/Th2 balance may be involved in the…”
    Get full text
    Journal Article
  4. 4

    The genomics of new drugs in sickle cell disease by Makis, Alexandros C, Hatzimichael, Eleftheria C, Stebbing, Justin

    Published in Pharmacogenomics (01-09-2006)
    “…The quality of life of patients with sickle cell disease in developed countries has improved significantly over the past two decades. Currently available…”
    Get more information
    Journal Article
  5. 5

    Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatment by Makis, AC, Hatzimichael, EC, Kolios, G, Bourantas, KL

    Published in Haematologica (Roma) (01-03-2004)
    “…Abnormal adhesion of red blood cells to the endothelium and the production of cytokines and vasoactive substances, such as endothelin-1 contribute to the…”
    Get full text
    Journal Article
  6. 6

    Alpha-2-macroglobulin and interleukin-6 levels in steady-state sickle cell disease patients by Makis, A C, Hatzimichael, E C, Mavridis, A, Bourantas, K L

    Published in Acta haematologica (01-01-2000)
    “…Endothelial activation and subclinical microvascular occlusions are an ongoing process during steady-state sickle cell disease, leading to interleukin…”
    Get more information
    Journal Article
  7. 7